336 related articles for article (PubMed ID: 36473894)
1. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents.
Cavallo I; Sivori F; Truglio M; De Maio F; Lucantoni F; Cardinali G; Pontone M; Bernardi T; Sanguinetti M; Capitanio B; Cristaudo A; Ascenzioni F; Morrone A; Pimpinelli F; Di Domenico EG
Sci Rep; 2022 Dec; 12(1):21104. PubMed ID: 36473894
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
Mias C; Mengeaud V; Bessou-Touya S; Duplan H
J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
[TBL] [Abstract][Full Text] [Related]
3. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates.
Kuehnast T; Cakar F; Weinhäupl T; Pilz A; Selak S; Schmidt MA; Rüter C; Schild S
Int J Med Microbiol; 2018 Dec; 308(8):1027-1035. PubMed ID: 30268774
[TBL] [Abstract][Full Text] [Related]
4. The Skin Microbiome: A New Actor in Inflammatory Acne.
Dréno B; Dagnelie MA; Khammari A; Corvec S
Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
[TBL] [Abstract][Full Text] [Related]
5. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study.
Zhang N; Yuan R; Xin KZ; Lu Z; Ma Y
Dermatol Ther (Heidelb); 2019 Dec; 9(4):735-746. PubMed ID: 31538294
[TBL] [Abstract][Full Text] [Related]
7. Acne microbiome: From phyla to phylotypes.
Dreno B; Dekio I; Baldwin H; Demessant AL; Dagnelie MA; Khammari A; Corvec S
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):657-664. PubMed ID: 37777343
[TBL] [Abstract][Full Text] [Related]
8. Myrtus communis and Celastrol enriched plant cell culture extracts control together the pivotal role of Cutibacterium acnes and inflammatory pathways in acne.
Mias C; Chansard N; Maitre M; Galliano MF; Garidou L; Mengeaud V; Bessou-Touya S; Duplan H
J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():12-19. PubMed ID: 36729401
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a 3D in vitro model mimicking acneic skin.
Laclaverie M; Rouaud-Tinguely P; Grimaldi C; Jugé R; Marchand L; Aymard E; Closs B
Exp Dermatol; 2021 Mar; 30(3):347-357. PubMed ID: 33354825
[TBL] [Abstract][Full Text] [Related]
11. Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris.
Mias C; Thouvenin MD; Gravier E; Dalmon S; Bouyer K; Alvarez S; Mengeaud V; Ribet V; Bessou-Touya S; Duplan H
J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():20-25. PubMed ID: 36729402
[TBL] [Abstract][Full Text] [Related]
12. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
[TBL] [Abstract][Full Text] [Related]
13.
Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding
Platsidaki E; Dessinioti C
F1000Res; 2018; 7():. PubMed ID: 30613388
[TBL] [Abstract][Full Text] [Related]
15. Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back.
Dagnelie MA; Corvec S; Saint-Jean M; Bourdès V; Nguyen JM; Khammari A; Dréno B
Acta Derm Venereol; 2018 Feb; 98(2):262-267. PubMed ID: 29136261
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
Farfán J; Gonzalez JM; Vives M
PeerJ; 2022; 10():e13553. PubMed ID: 35910763
[TBL] [Abstract][Full Text] [Related]
17. Biofilm of Cutibacterium acnes: a target of different active substances.
Ruffier d'Epenoux L; Fayoux E; Veziers J; Dagnelie MA; Khammari A; Dréno B; Corvec S
Int J Dermatol; 2024 May; ():. PubMed ID: 38760974
[TBL] [Abstract][Full Text] [Related]
18. Polylysine dendrigraft is able to differentially impact Cutibacterium acnes strains preventing acneic skin.
Attia-Vigneau J; Barreau M; Le Toquin E; Feuilloley MGJ; Loing E; Lesouhaitier O
Exp Dermatol; 2022 Jul; 31(7):1056-1064. PubMed ID: 35231149
[TBL] [Abstract][Full Text] [Related]
19. Acne fulminans and Cutibacterium acnes phylotypes.
Bocquet-Trémoureux S; Corvec S; Khammari A; Dagnelie MA; Boisrobert A; Dreno B
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):827-833. PubMed ID: 31715640
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
